Nanomaterials for cancer nanomedicine: Case studies
Cancer nanomedicine has emerged as a highly promising approach for improving the effectiveness and safety of cancer therapy. Nanoparticles have been engineered to selectively target cancer cells, overcome biological barriers, and deliver a wide range of therapeutic payloads including small molecules, nucleic acids, and proteins.
Recent advancements in nanomaterial design, synthesis, and characterization have enabled the development of highly precise and efficient nanoparticles for cancer diagnosis and treatment. Learn how nanoComposix has supported therapeutic development in this field with this collection of case studies.
You will learn about
- Functionalized silica coated iron oxide nanoparticles targeting a prostate-specific antigen
- Targeted delivery of a therapeutic oligonucleotide, from development to GMP manufacturing
- GMP documentation and manufacturing of a cell-based cancer therapy using mesoporous silica
